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Abstract 
Purpose: Oxytocin’s anorexigenic effects have been widely documented and accepted; 
however, no paper has yet used the Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis (PRISMA) guidelines to compile previous findings in a single systematic 
review and quantitative meta-analysis. The current paper aimed to identify published and 
unpublished studies examining the effects of oxytocin on energy intake in animals and 
humans, and the factors that moderate this effect. 
Methods: Web of Science, Pub Med, and Ovid were searched for published and unpublished 
studies reporting the effects of oxytocin on energy intake in wild-type animals and in 
humans, when administered in the absence of other active drugs or surgery.  
Results: 2049 articles were identified through the original systematic literature search, from 
which 54 articles were identified as relevant for inclusion in this review. An additional 3 
relevant articles were identified in a later update of the literature search. Overall, a single-
dose of oxytocin was found to reduce feeding in animals. Despite several individual studies 
which found that this effect persists to the end of the third week of chronic administration in 
rodent models, overall, this anorexigenic effect did not hold in the meta-analyses testing the 
effects of chronic administration. There was no overall effect of oxytocin on energy intake in 
humans, although a trend was identified for oxytocin to reduce consumption of solid foods. 
Conclusions: Oxytocin reduces energy intake when administered as a single dose. Oxytocin 
can inhibit feeding over two- to three-week periods in rodent models. These effects typically 
do not persist beyond the third week of treatment. The anorexigenic effect of oxytocin is 
moderated by pregnant status, dose, method of administration, and diet composition. 
KEYWORDS: OXYTOCIN; ENERGY INTAKE; FEEDING; ANIMALS; HUMANS   
Introduction 
 Verbalis and colleagues 2 and Kirchgessner3 first proposed a link between oxytocin 
and the control of food intake almost 30 years ago; which was subsequently corroborated by 
the Arletti lab 1. Today, oxytocin has a well-established and well-accepted role in reducing 
food intake in rodents, although these effects have been found to be conditional on several 
factors 4.  
 The reported inhibitory effect of oxytocin on feeding has taken on new relevance in 
the face of the high prevalence of obesity in developed countries 5 and recognition of the 
psychological and functional difficulties faced by individuals with binge-type eating 
disorders, including bulimia nervosa and binge eating disorder 6, 7. It has, accordingly, been 
proposed that oxytocin may be a useful supplement to administer to counter overeating and 
obesity 8, 9. 
 In recent years, several narrative reviews have examined the role of oxytocin in a 
variety of functions related to the homeostasis of energy status: including its effects on 
feeding, energy expenditure, lipolysis, glucose homeostasis, and macronutrient preference 9-
12, as well as its potential to regulate disordered eating in humans 13. However, systematic 
reviews and meta-analyses in the style of the Preferred Reporting Items for Systematic 
Reviews and Meta-Analysis (PRISMA) guidelines are not commonly used in neurobiology 
and have not been previously used to estimate the size of the effect of oxytocin on feeding, 
and its possible moderators. This systematic method offers benefits such as the 
reproducibility, accountability of the search methods used, and quantitative precision in the 
measurement of effect size across different samples 14. De Vries and colleagues have 
therefore adapted similar guidelines for systematic reviews of animal intervention studies in 
order to bring these same benefits in methodical rigor to animal research 15. 
The current paper therefore aimed to use this rigorous methodology to synthesize 
oxytocin’s effects on feeding. We used PRISMA guidelines to identify all original published 
and unpublished experiments testing the effects of exogenous oxytocin on energy intake in 
wild-type animals and in humans, where oxytocin was administered in the absence of other 
active drugs or surgeries. Following this, we then identified subsets of experimental designs 
conducive to synthesis by quantitative meta-analysis. We also aimed to identify relevant 
moderators of oxytocin’s effects on feeding in order to clarify the conditions under which 
these anorexigenic effects hold. 
Methods 
Search Strategy and Eligibility Criteria 
Two of the authors conducted a systematic literature search to identify original studies 
which had administered exogenous oxytocin to either animals or humans, and compared its 
effects on energy intake with a placebo condition. This search was conducted following 
PRISMA guidelines 14. We followed reporting guidelines suggested by de Vries and 
colleagues for pre-clinical intervention studies in the data extraction and reporting methods 
described below 15. 
 The search terms included in the literature search were: “oxytocin” AND (“feed*” OR 
“food” OR “eat” OR “consum*” OR “intake” OR “hunger” OR “satiety” OR “appetite” OR 
“meal”). The eligibility criteria for studies included in the systematic review are as follows: 
Inclusion criteria: 
• Original experiment 
• Independent variable: Administration of exogenous oxytocin compared to placebo 
• Dependent variable: Quantity of food or nutritive substance consumed 
• Oxytocin administered in isolation from any other drug or neural stimulation 
• Article available in English 
• Neurologically typical participants (e.g., participants with Prader-Willi Syndrome 
were excluded) 
 
Exclusion criteria: 
• Studies testing consumption of alcohol/ethanol or methamphetamines 
• Studies testing consumption of plain water, saccharin, or sodium solutions 
• Studies of breastfeeding neonates 
• Studies measuring oxytocin’s effect on conditioned taste aversion 
 
In March 2016, these terms were included in a title or topic search in the Web of 
Science (Core Collection) and in a text word search in PubMed. In November 2016, these 
same search terms were entered into a literature search using the following Ovid resources: 
International Pharmaceutical Abstracts, Ovid MEDLINE(R) I-Process & Other Non-Indexed 
Citations, Ovid MEDLINE R, PsycArticles Full Text, PsycInfo, Ovid MEDLINE(R) Epub 
Ahead of Print. The PubMed and Web of Science searches were then updated by the first 
authors in December 2016. 
 The first author then proceeded to screen the reference lists of relevant reviews in 
order to identify articles not included in the main search results, and independently contacted 
authors known to have unpublished eligible studies (identified through individual 
correspondence, conference attendance, and reference to unpublished data within a published 
paper). In March 2017, the second author repeated the literature search among the same 
databases. The first and second authors discussed discrepancies among the identified search 
results until a consensus regarding each article’s eligibility was reached. The literature search 
was once again updated using the same databases in July 2017. Basic study characteristics 
(including sample information, dose of oxytocin administration, and duration of feeding 
measurement) and a qualitative summary of each experiment’s findings were extracted by a 
single author. 
Meta-Regression 
 Given the wide variety of studies identified by the systematic literature search, we 
opted to conduct five separate meta-regressions in order to maximize the homogeneity within 
each analysis. The five meta-regressions were then conducted amongst each of the following 
sets of experiment: 1) single-dose animal studies measuring feeding over one hour after a 
central injection of oxytocin; 2) single-dose animal studies measuring feeding over one hour 
after systemic administration of oxytocin; 3) chronic-dosing animal studies administering 
central injections of oxytocin; 4) chronic-dosing animal studies administering systemic 
injections of oxytocin; 5) human studies. Effect size data (including raw means and standard 
deviation or standard error) and sample sizes for each study were necessary for each eligible 
study to be included in a meta-regression. These data were extracted by a single author 
directly from tables or text within the paper in cases where they were reported. For papers in 
which these data were not reported, the authors of the paper were contacted with a request for 
this information via e-mail, or via Research Gate where a current valid e-mail address was 
unavailable. Where these data were unavailable, the eligible paper has been described in the 
results of the systematic review, but omitted from the meta-regression by necessity. 
As not all of the studies identified in original systematic review were eligible for 
inclusion in one of these meta-regressions, the full findings of each study included in the 
systematic review have been reported in separate tables. The moderating and mediating 
factors influencing oxytocin’s effects on energy intake have been summarized in a qualitative 
synthesis, which follows the quantitative results reported below. 
 Each meta-regression was conducted as a random-effects multi-level analysis with 
autoregressive structure, where the second-level corresponded to a specific sample of test 
subjects. The meta-regressions’ results are reported in terms of the standardized mean 
difference between placebo and oxytocin conditions. The meta-regressions were conducted 
using the escalc and rma.mv commands in the metafor package for R 16. The forest plots and 
bias plots were generated using the Comprehensive Meta-Analysis software. In four 
experiments within the meta-analysis for human studies, the within-subject correlation was 
not available. The average within-subject correlation for human studies (0.61) was therefore 
imputed for these experiments. 
 
Results 
Systematic Review 
The quantity of papers identified and screened at each step of the PRISMA process 
during the original systematic literature search is presented in Figure 1. Two additional 
unique papers were identified through the updated literature search, and one additional paper 
was identified through author correspondence. The original and updated literature searches 
together identified a total of 57 relevant papers.  
Forty-seven papers included at least one experiment that measured the effects of a 
single dose of oxytocin on feeding. The 114 experiments measuring the effects of a single 
dose of oxytocin are summarized in Supplementary Table 1. Eighteen papers included at least 
one experiment that administered chronic dosing of oxytocin. The 56 experiments measuring 
the effects of chronic oxytocin dosing on feeding are summarized in Supplementary Table 2. 
Meta-Regression 
 Acute central animal studies. We first conducted the meta-regression for the 
studies that administered oxytocin centrally, entering moderators for Dose and Body Mass. 
As all animals were male and housed individually, we did not include moderators for gender 
or socialization. The Cook’s plot generated by this analysis revealed that one study (Arletti et 
al., 1989 1, Experiment 2a) yielded undue influence on the results. This study was therefore 
excluded from the final analysis, resulting in a total of nine experiments with a pooled sample 
size of 150 observations. (Note: as several studies incorporated a within-subjects design 
and/or repeated experiments using the same animals, the number of total observations does 
not equal the total number of subjects.) The final analysis found a significant main effect of 
oxytocin, showing that a single dose of centrally-administered oxytocin reduced feeding with 
a large effect size (d = -1.26, SE = 0.451, p = 0.005, 95% CI [-2.149, -0.380]). The forest plot 
for this meta-regression is shown in Figure 2. Neither of the included moderators was 
significant: Dose (estimate = -0.003, SE = 0.017, p = 0.857, 95% CI [-0.036, 0.030]); Body 
Mass (estimate = 0.000, SE = 0.000, p = .315, 95% CI [-0.000, 0.000]). There was significant 
residual heterogeneity: Q(8) = 22.94, p = 0.003. There was significant residual heterogeneity 
after controlling for Dose (QE(7) = 22.94, p = 0.002 and Body Mass QE(7) = 20.49, p = 
0.005. 
 Acute systemic animal studies. We next repeated the analysis for studies 
administering a single dose of systemic oxytocin including moderation analyses for Gender, 
Dose, and Body Mass. This meta-regression included findings from 26 experiments and 510 
observations. All animals were individually housed; therefore, socialization was not entered 
as a moderator. Visual inspection of the Cook’s plot did not reveal undue influence of any 
study (all values < 0.12). This analysis for single-dose studies administering oxytocin 
systemically also found that oxytocin significant reduced feeding with a large effect size (d = 
-1.17, SE = 0.307, p < .001, 95% CI [-1.776, -0.574]). There was significant heterogeneity in 
the results: Q(25) = 188.38, p < .001. The moderation analyses revealed a small dose-
response effect (estimate = -0.002, SE = 0.0005, p < .0001, 95% CI [-0.003, -0.001]). The 
forest plot for this meta-regression is shown in Figure 3. Neither of the other included 
moderators were significant: Gender (estimate = 0.48, SE = 1.220, p = .694, 95% CI [-1.912, 
2.872]); Body Mass (estimate = 0.008, SE = 0.005, p = .091, 95% CI [-0.001, 0.017]). There 
was significant residual heterogeneity after controlling for each moderator: Dose (QE(d24) = 
104.31, p < .001); Gender (QE(24) = 187.81, p < .001); Body Mass (QE(24) = 131.74, p < 
.001). 
 Chronic central animal studies. For the meta-regression of animal studies 
administering repeated central injections of oxytocin we entered the following moderators: 
Gender, Dose, Body Mass, and Duration of Oxytocin Administration. The quantity of energy 
intake on the final day of feeding measurement was compared between oxytocin and placebo 
conditions. Data were drawn from 20 experiments with a total of 349 observations. As all 
animals were housed alone, socialization was not included as a potential moderator. Visual 
inspection of the Cook’s plot did not reveal undue influence of any study (all values < 0.30). 
This analysis did not find a significant main effect of oxytocin on feeding when administered 
centrally in chronic infusions (d = 0.15, SE = 0.171, p = .379, 95% CI [-0.185, 0.485]). The 
forest plot for this meta-regression is shown in Figure 4. There was significant heterogeneity: 
Q(19) = 43.08, p = 0.001. None of the included moderators were significant, and there was 
significant residual heterogeneity after controlling for each moderator. The results of all 
moderation analyses are presented in Table 1. 
 Chronic systemic animal studies. The same analysis was then repeated for animal 
studies that administered chronic infusions of oxytocin systemically. The quantity of energy 
intake on the final day of feeding measurement was compared between oxytocin and placebo 
conditions. Seventeen experiments with a total of 255 observations were included in this 
meta-regression. We entered the following moderators: Gender, Dose, Body Mass, Duration 
of Administration, and Social Condition. Visual inspection of the Cook’s plot did not reveal 
undue influence of any study (all values < 0.90). Again, we did not find a significant main 
effect of oxytocin on feeding (d = -1.52, SE = 0.963, p = .115, 95% CI [-3.407, 0.369]). The 
forest plot for this meta-regression is shown in Figure 5. The moderators Gender, Dose, and 
Duration of Administration were significant. Oxytocin had a significantly greater 
anorexigenic effect in males, and the inhibitory effect of oxytocin on feeding decreased in 
magnitude over time. The results for dose indicated a reverse dose-response effect, such that 
greater dose was associated with less inhibition of oxytocin on feeding; however, the effect 
size was close to zero (estimate = 0.0002, SE = 0.0001, p = 0.039, 95% CI [0.0000, 0.0003]. 
There was significant heterogeneity in study results (Q(22) = 206.88, p < .001) and 
significant residual heterogeneity after controlling for each moderator. The results of all other 
moderator analyses are reported in Table 2. 
Human studies. The meta-regression for human studies included 21 experiments with 
a total of 1020 observations. We entered the following moderators: Liquid-versus-Solid 
Food, Gender, Dosage, Fasted-versus-Full condition, Duration of Feeding, and Diagnosis. 
Visual inspection of the Cook’s plot did not reveal undue influence of any study (all values 
< 0.8). This analysis did not find a significant main effect of oxytocin on feeding (estimate = 
-0.10, SE = 0.075, p = 0.194, 95% CI [-0.245, 0.050]). The forest plot for this analysis is 
shown in Figure 6. 
There was significant heterogeneity between studies: Q(df = 20) = 55.82, p < .001. 
All moderators except for Dose and Diagnosis were found to be significant (results shown in 
Table 3). Oxytocin reduced feeding to a greater degree for solid, rather than liquid foods 
(e.g., nutrient drinks, juice and smoothies). There was a greater inhibitory effect of oxytocin 
on feeding for males than females, when participants were full, rather than fasted, and when 
food was presented for a longer period of time (although the effect size was close to zero). 
There was a marginally significant effect such that oxytocin reduced feeding to a greater 
degree in obese participants. A greater dose of oxytocin was not associated with quantity of 
food consumption. There was significant residual heterogeneity after taking each moderator 
into account. Residual heterogeneity for each moderator is reported in Table 3. 
Based on the difficulty of interpreting the results given such a range of significant 
moderators, we then proceeded to repeat the analysis including only studies that had 
measured the consumption of solid foods. As all but one of the studies in the meta-regression 
for solid foods included only female participants, the gender moderator was not included in 
this analysis.  
Ten experiments with a total of 486 observations were included in the meta-
regression for human studies measuring consumption of solid foods. Visual inspection of the 
Cook’s plot did not reveal undue influence of any study (all values < 0.7). The meta-
regression for human studies isolated into the solid food condition found a marginally 
significant main effect of oxytocin on food consumption with a small effect size (d = -0.25, 
SE = 0.132, p = 0.055, 95% CI [-0.510, 0.006]). The forest plot for this meta-regression is 
shown in Figure 7. None of the included moderators were significant (results shown in Table 
4). There was significant residual heterogeneity after controlling for Gender, Fasted or Full 
condition, Duration of Administration, and Dose. Although the diagnosis moderator was not 
significant (Qm(3) = 3.01, p = 0.391), there was no longer significant residual heterogeneity 
after controlling for diagnosis (QE(6) = 12.18, p = .058). 
Publication Bias. The funnel plots associated with each meta-regression are shown in 
Supplementary Figures 1-5. The funnel plots indicated that most studies had a moderate 
degree of precision, with a broad range of effect sizes reported. These findings do not suggest 
systematic publication bias towards paper with either strong or weak effect size. 
Mediators and Moderators of Oxytocin’s Anorexigenic Effects 
 Among the systematic review, there were many factors that were found to moderate 
the effect of oxytocin on feeding in some studies, including: sex of the animal, pregnancy, 
dose, method of administration, setting, and dietary factors. As not all studies met criteria for 
inclusion in one of the meta-regressions, the following reported results will focus on a sample 
of other identified studies that examined a moderating or mediating factor in a controlled 
experimental design. 
 Sex differences. Several studies investigated sex differences in oxytocin’s effects on 
feeding. Bjorkstrand and Uvnas-Moberg 17 found that a 5g intracerebroventricular injection 
of oxytocin increased feeding in female, but not male rats. Conversely, Zhou, Ghee, See and 
Reichel 18 found that oxytocin induced a greater reduction in feeding in female rats, with 
anorexigenic effects observed at 0.3, 1, and 3mg/kg doses of oxytocin, while only the 3mg/kg 
dose was effective at reducing feeding in males. To further add to these mixed findings, 
Benelli, Bertolini and Arletti 19 failed to find any differences in male versus female rats’ 
response to oxytocin’s effects on feeding. Previous studies have demonstrated that feeding 
varies across differing stages of the oestrous cycle in rodents, non-human primates, and 
humans 20-22. The feeding response to hunger-related hormones (including ghrelin) and 
neurosteroids also varies throughout different stages of the estrous cycle in female rats 23. It is 
recommended that future studies continue to investigate the extent to which estrous cycle 
phase and fluctuations in ovarian hormones may influence the satiety response to oxytocin in 
female animal models. 
 Pregnancy. Only one study 24 tested the effect of pregnancy as a moderator for 
oxytocin’s effect on feeding. This study identified that 1g intracerebroventricular injection 
decreased feeding in virgin female rats over one hour of measurement, while having no 
continued effect on feeding over 12 hours. However, a different pattern of effects was 
observed in pregnant rats, with the same dose of oxytocin exerting no effect on feeding over 
one hour, while increasing feeding over 12 hours. The authors have proposed that this may be 
due to changes in the expression and binding affinity of central oxytocin receptors during 
pregnancy 24.  
 Dose and method of administration. Most studies testing a dose-response effect of 
oxytocin found that greater doses of oxytocin were associated with correspondingly lower 
levels of subsequent feeding. The minimum effective dose required to observe anorexigenic 
effects of oxytocin depended on the method of administration, with central injections of 
oxytocin requiring much lower doses than peripheral injections.  
Findings of note include that of Ong, Alhadeff and Grill 25, who reported that a 
1g/1L dose of oxytocin injected into the fourth ventricle reduces feeding over 30 minutes 
only when a dietary preload had been provided, and did not continue to affect feeding over 
1.5 hours. By contrast, a 0.3g dose of oxytocin injected into the nucleus of the solitary tract 
(NTS) was found to significantly reduced feeding over 30 minutes regardless of whether a 
dietary preload had been provided. This inhibitory effect on feeding persisted over 1.5 hours 
in the dietary preload condition. These findings seem to point to greater sensitivity to 
oxytocin’s effects on feeding within the NTS than within hindbrain receptors accessed via 
fourth cerebral ventricle, suggesting that the NTS may represent a more proximal site 
mediating oxytocin’s effects on feeding. However, these results contradict those found by Ho 
and colleagues 26, who reported that oxytocin injection into the fourth ventricle was effective 
at reducing feeding in the absence of a preload at a dose of 1g. The differential sensitivity of 
the NTS and fourth ventricle to oxytocin’s anorexigenic effects is therefore a question that 
would be interesting for future research to explore.    
 In another study examining the impact of injecting oxytocin into different regions of 
the central nervous system, Herisson, Waas, Fredriksson, Schioth, Levine and Olszewski 27 
demonstrated that 1g and 3g doses of oxytocin injected directly into the nucleus 
accumbens core reduces both chow intake and the consumption of a 10% sucrose solution in 
male rats, while these inhibitory effects are not observed when the same dose is injected into 
the nucleus accumbens shell. The administration of oxytocin into the nucleus accumbens core 
was associated with increased Fos-immunoreactivity in both the nucleus accumbens core 
itself, as well as the paraventricular nucleus and supraoptic nucleus of the hypothalamus: two 
regions dense in oxytocin neurons and receptors which are involved in feeding regulation 28. 
These findings therefore support a potential role of the nucleus accumbens core in mediating 
oxytocin’s anorexigenic effects, which does not extend to the nucleus accumbens shell. 
 One point to note, however, are that most studies administered high supraphysiologic 
doses of oxytocin. While these doses may be required in the case of peripheral administration 
to increase the chances that some oxytocin will cross the blood-brain barrier, it ought to be 
noted that these findings may reflect partial oxytocin binding with vasopressin receptors at 
high doses that would not occur at physiological levels. 
 Social setting. The social conditions in which animals were housed was also found to 
impact the effect of oxytocin on feeding. Grippo, Trahanas, Zimmerman, Porges and Carter 29 
found that isolating female prairie voles from litter-mates resulted in a decrease in sucrose 
intake over a period of two weeks in a placebo condition, but that this effect was prevented 
by oxytocin. In the co-housed group of prairie voles, however, there were no changes in 
sucrose intake over time, or any differences between the oxytocin and placebo conditions. 
Additionally, Herisson, Waas 27 found that central oxytocin administration reduced food and 
sucrose intake in individually-housed male rats, while neither of these effects were observed 
in male rats allowed some social contact with a conspecific. Both of these studies point to the 
potential for social housing to prevent oxytocinergic reductions in feeding that would 
otherwise occur in isolated social settings.  
Dietary factors. Finally, diet-induced obesity was also identified as an important 
moderating factor for oxytocin’s effects on feeding in both animals and humans 8, 30-34. On the 
whole, direct comparisons of lean animals consuming standard chow with diet-induced obese 
animals consuming high-fat diets found that oxytocin had more consistent inhibitory effects 
on feeding in the dietary-induced obese animals 8, 31. Blevins and colleagues have shown that 
this moderating effect persists in high fat diet-fed rats, even when matched for body mass and 
adiposity with chow-fed controls 31, thus indicating that this moderating effect may be more 
attributable to the fat-content of the animal’s diet than body composition. 
 
Discussion 
This review aimed to identify published and unpublished studies testing the effects of 
exogenous oxytocin on energy intake in wild-type animals and humans, where oxytocin was 
administered in isolation from other active drugs and surgery. The systematic review and 
meta-analysis revealed a robust inhibitory effect of oxytocin on energy intake when 
administered as a single dose in animals, regardless of whether it was administered via a 
central or peripheral route. Additionally, while several individual experiments did show a 
continued inhibitory effect of oxytocin for periods of two or more weeks in rats and mice 8, 31, 
35-39, when final-day energy intake was compared between placebo and oxytocin conditions in 
the quantitative meta-analysis this inhibitory effect did not hold, despite a trend towards 
inhibition in studies administering oxytocin systemically.  
The human studies did not find a main effect of oxytocin on energy intake; however, 
there was found to be a trend towards a decrease in the consumption of solid foods induced 
by oxytocin. Additionally, oxytocin had a stronger inhibitory effect on energy intake in male 
participants, in obese participants, and when participants completed the experiment in the full 
condition (rather than fasted condition). The specific finding that oxytocin reduced feeding to 
a greater degree in obese humans 30 is consistent with findings from animal studies, which 
have also indicated a greater anorexigenic effect in diet-induced obese mice and rats 8. 
The moderating effect of liquid versus solid foods was unexpected amongst human 
studies, particularly given previous animal research demonstrating the inhibitory effect of 
oxytocin on the consumption of palatable liquid solutions  27, 40, 41. The mechanism driving 
the difference between oxytocin’s effect on liquid and solid foods is unclear. One hypothesis 
is that oxytocin may reduce gastric motility, thus contributing to the sensation of satiety as 
solid food remains in the gut for a longer period of time. This hypothesis is supported by 
research demonstrating that oxytocin can reduce gastric motility in rats 42-45 and mice 46. 
However, Borg and colleagues have found evidence to the contrary, indicating that oxytocin 
does not affect gastric emptying rate in humans following consumption of a liquid meal 47. 
Further research would be useful to test this hypothesis as it pertains to solid foods, and to 
further investigate the reasons for oxytocin’s greater inhibitory effect for solid, versus liquid, 
consumption in humans.  
The pattern for the inhibitory effect of oxytocin on feeding to decrease over time was 
reflected in a significant moderator analysis carried out for the meta-regression of studies that 
administered systemic oxytocin to animals chronically over time. This meta-regression, as 
well as the meta-regression for human studies, were also significantly moderated by sex, such 
that the effects of oxytocin on reducing feeding were significantly greater for male animals. 
This overall moderating effect of sex across studies included in the meta-regression is 
interesting to observe given the highly mixed findings regarding sex differences reported in 
individual studies 17-19. A greater density of oxytocin receptors has previously been reported 
within the spinal cord and ventromedial hypothalamus of male rats 48, which may potentially 
explain the greater sensitivity to oxytocin’s anorexigenic effects in males. However, the 
activity of oxytocin and oxytocin receptors also varies across stages of the follicular cycle in 
female prairie voles 49. Furthermore, it is known that levels of endogenous plasma oxytocin 
vary across stages of the menstrual cycle in humans 50. One can hypothesize that this natural 
variation may moderate the effects of exogenously-administered oxytocin. Variation in the 
follicular stage at which oxytocin was administered to female animals may therefore partially 
account for mixed findings reported for feeding effects in previous studies. It would therefore 
be useful to specifically investigate variation in oxytocin’s effect on feeding across different 
phases of the follicular cycle, and associated variation in plasma levels of other hormones 
(e.g., oestrogen).  
In terms of the mechanisms explaining oxytocin’s greater effect in obese animals and 
humans, it is known that oxytocin receptors exhibit a higher-affinity binding state in the 
presence of cholesterol 51. Therefore, it may be that a greater fat- and cholesterol-rich diet at 
least partially explains the greater anorexigenic effects of oxytocin observed in obese animals 
and humans. 
The mechanisms and neural circuits explaining the overall anorexigenic effects of 
oxytocin are still somewhat uncertain. Oxytocin is known to mediate the anorexigenic effects 
of cholecystokinin (CCK), which acts on oxytocin neurons via vagal afferents from the gut 2. 
This finding has received further support from research demonstrating that injections of 
oxytocin into the third cerebral ventricle enhance the anorexigenic effects of low doses of 
CCK-8 31 while, conversely, pre-treatment of an oxytocin receptor antagonist into the fourth 
ventricle suppresses the anorexigenic effects of CCK 52, 53 . In addition to this role mediating 
the effects of CCK, oxytocin has also been implicated in mediating leptin’s 54, 55 and nesfatin-
1’s 56 inhibitory effects on food intake. The downstream mechanisms by which oxytocin 
impacts on feeding; however, are less certain.  
It is likely that central and peripheral oxytocin exert effects of feeding via different 
mechanisms. Previous research has identified that only approximately 0.002% of peripheral 
oxytocin crosses the blood-brain barrier where it might access central receptors 57. However, 
the extent to which peripheral oxytocin exerts its effects via central versus peripheral 
receptors, such as those in the gut 58, may be species-dependent. In mice, the literature 
supports a role for vagal afferent nerves in mediating the anorexigenic effect of peripheral 
oxytocin 59, 60. This interpretation draws support from research finding that oxytocin receptors 
are expressed in the nodose ganglion of the vagus nerve 59, as well as further research that has 
gone on to demonstrate that vagotomy results in an attenuation of the anorexigenic effect of 
peripherally-administered oxytocin in mice 60. In rats, however, Ho and colleagues 26 have 
demonstrated that hindbrain receptors accessed via the fourth ventricle are predominantly 
responsible for mediating the inhibitory effects of peripheral oxytocin on feeding. Further 
research clarifying which pathway/s predominate this mediating effect in primates and 
humans has not yet been conducted, and would be useful to investigate in future studies. 
Brain nuclei including the paraventricular nucleus, NTS, and arcuate nucleus have 
been implicated as potentially relevant in mediating oxytocin’s effects on feeding 25, 60-63. 
This evidence comes from studies indicating the direct injections of oxytocin into these areas 
suppresses food intake 25, 61, as well as immunohistological studies demonstrating that the Fos 
activation of oxytocin neurons in these regions co-occurs with the termination of feeding 60-
63. Furthermore, studies have demonstrated that injections of oxytocin directly into the ventral 
tegmental area, nucleus accumbens core, and ventromedial hypothalamus are effective in 
inhibiting feeding; thereby indicating that these regions may mediate the anorexigenic effects 
of oxytocin as well 27, 41, 64. Given that oxytocin is effective in reducing energy intake when 
administered both centrally and peripherally, it may be the case that oxytocin acts as a central 
messenger integrating central and peripheral signals. This hypothesis, however, requires 
further evidence to corroborate. 
It has also been proposed that oxytocin may exert inhibitory effects on energy intake 
via a physiological pathway mediated by reward-based mechanisms 65. This hypothesis is lent 
support by the high density of oxytocin receptors along the pathways connecting the nucleus 
accumbens and ventral tegmental area 66-68, two regions known to be highly involved with 
processing food reward 69. Additionally, oxytocin injected directly into the nucleus 
accumbens has been found to reduce methamphetamine-induced place preference 70 and 
prevent relapse to methamphetamine-seeking behavior after extinction 71. Together, these 
findings point to an ability for oxytocin to disrupt reward-related processing in these regions, 
which may additionally extend to suppressing reward-based feeding behaviour. This 
hypothesis, if true, may also explain the stronger effects of oxytocin in reducing hedonic, as 
opposed to hunger-driven, feeding in human studies 30, 72, 73. Further research in animals and 
humans would be useful to test this hypothesis further, and elucidate the precise mechanisms 
of oxytocin’s acute action on energy intake. 
The confirmation of oxytocin’s anorexigenic effects when administered as a single 
dose echoes conventional understanding in the literature, while highlighting the limits of this 
effect: such as the reverse (orexigenic) effect observed in pregnancy 24 and when socially-
housed animals subsequently undergo separation from litter-mates 29. The null findings 
revealed in the meta-analysis testing the chronic effects of oxytocin on feeding are 
disappointing in the context of potential hopes for developing oxytocin supplementation as a 
new treatment for binge-type eating disorders in humans, and conflict with individuals 
studies which have reported the persistence of oxytocin’s anorexigenic effects over two to 
three weeks of measurement in rats and mice 8, 31, 36, 38, 74, 75, and for two weeks post-treatment 
in rhesus monkeys 39. It may be the case that a regime of intermittent oxytocin administration 
would result in the same anorexigenic effects observed within the course of a single 
experimental administration, without resulting in the same degree of receptor adaptations. 
Future research testing different temporal regimes of oxytocin administration is 
recommended to test this hypothesis.  
The diminishing effects of oxytocin are in keeping with the results arising from 
individual studies making use of the repeated administration of oxytocin 8, 31, 33, 36, 37 or an 
oxytocin agonist 76.  These findings also concord with social experiments which have found 
that the anxiolytic effects of oxytocin disappear or reverse over time 77. Peters et al. found 
that the reversal of acute anxiolytic effects over chronic dosing was associated with a 
concurrent reduction in oxytocin receptor binding. Indeed, previous work has shown that 
oxytocin receptor binding can reduce by as much as 50% over 10 days of chronic 
administration, driven largely by down-regulation of the oxytocin receptor 78. It is therefore 
likely that this reduced binding potential may explain the dampening of oxytocin’s effects on 
feeding.  
The null findings generated from the meta-regressions of chronically-administered 
oxytocin studies should be interpreted with some degree of caution. Although the final-day 
analyses used for the meta-regressions maximized the number of commensurable studies 
eligible for inclusion, it may be that noise in the data on the final day data masked smaller 
effects identified by studies that compared average consumption across several days. It 
should also be noted that the scope of the current review is limited to oxytocin’s effects on 
energy intake alone, and that oxytocin’s effects on other metabolic parameters deterring 
obesity (e.g., lipolysis, brown adipose tissue thermogenesis, and energy expenditure) may 
persist with chronic administration 74.  
Limitations of the current review include some inherent drawbacks of the 
methodology chosen for the meta-regressions. We aimed to reach a compromise between 
maximizing homogeneity of studies included in the meta-regression, while also including the 
maximum number of experiments. The choice to therefore include only single-dose studies 
that measured the effects of oxytocin over one hour of feeding therefore constrained these 
meta-regressions to a reasonable scope and similar effect size. Differences in the exact 
location of administration and animals included in each experiment, however, may have 
added to the heterogeneity of effect size observed across studies. Furthermore, the current 
systematic review did not include findings from non-wild-type animals (e.g., Sim-
haploinsufficient rats and mice) or animals whose nervous systems were altered by surgery or 
direct stimulation. Therefore, although the current findings reveal the effects of exogenous 
oxytocin in wild-type animals, it should be noted that there are further findings reflecting the 
implication of oxytocin on feeding that were not included within the scope of the present 
review. 
Regarding the clinical implications of these findings, it is particularly encouraging to 
have observed that the anorexigenic effects of oxytocin were stronger for populations that 
suffer from over-eating and binge-eating. These findings suggest that, in the short term, 
oxytocin may reduce the likelihood of binge-eating and overeating for populations with 
obesity, bulimia nervosa, and binge eating disorder. However, the null findings from the 
meta-regressions of chronic animal studies cast doubt on the persistence of oxytocin’s acute 
effects. Testing different dosing schedules of oxytocin would be useful for identifying a 
potential frequency and dose of administration that maintains oxytocin’s beneficial effects 
over time, without resulting in the reduction of receptor binding. 
In conclusion, the current systematic review has confirmed the anorexigenic effect of 
a single dose of oxytocin in animals first documented by the Arletti lab 1, while 
demonstrating that this anorexigenic effect does not persist throughout chronic dosing. There 
was a trend for intranasal oxytocin to reduce feeding in humans, and this effect was stronger 
for individuals with obesity, bulimia nervosa, and binge eating disorder. Future research is 
needed to further elucidate the mechanisms of these effects, and whether differing dosing 
schedules might prevent their attenuation with chronic administration. 
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Tables and Figures 
Figure 1. PRISMA flow diagram for the original systematic literature search 
Figure 2.  Forest plot of studies measuring the effect of a single-dose of central oxytocin on 
energy intake over a one-hour measurement duration in animals. RLCV = right lateral 
cerebral ventricle; 4V = fourth cerebral ventricle; VMH = ventromedial hypothalamus; ICV = 
intracerebroventricular. 
 
Figure 3. Forest plot of studies measuring the effect of a single-dose of systemic oxytocin on 
energy intake over a one-hour measurement duration in animals. 
 
Figure 4. Forest plot of studies measuring the effect of chronic dosing of central oxytocin on 
energy intake in animals. ICV = intracerebroventricular; 3V = third cerebral ventricle; 4V = 
fourth cerebral ventricle. 
 
Figure 5. Forest plot of studies measuring the effect of chronic dosing of systemic oxytocin 
on energy intake in animals. 
Figure 6. Forest plot of studies measuring the effect of a single-dose of intranasal oxytocin 
on energy intake in humans. 
 
Figure 7. Forest plot of studies measuring the effect of a single-dose of intranasal oxytocin 
on solid food intake in humans. 
 
 
 
Table 1: Results of Moderator Analyses for Chronic Central Animal Studies 
* p < .05; *** p < .001. 
Table 2: Results of Moderator Analyses for Chronic Systemic Animal Studies 
* p < 0.05. 
 
 
Table 3: Results of Moderator Analyses for All Human Studies 
* p < .05; ** p < .01; *** p < .001. 
 
Table 4: Results of Moderator Analyses for Human Studies Measuring Solid Food Intake 
Supplementary Table 1: Summary of studies administering a single dose of oxytocin 
Note. AcbC = nucleus accumbens core; AcbSh = nucleus accumbens shell; NTS = nucleus of 
the solitary tract. Seventy-one of these experiments found that oxytocin reduced feeding for 
at least one time point measured, 39 experiments found no effect of oxytocin on feeding, and 
4 experiments found that a single dose of oxytocin increased feeding. 
 
 
Supplementary Table 2: Summary of studies administering chronic oxytocin treatment 
 
Note. Twenty-seven experiments found that oxytocin reduced feeding at some point 
following at least 3 days of treatment, 27 found no significant effects of oxytocin on feeding, 
and 2 found that chronic dosing of oxytocin increased feeding 
 
Supplementary Figure 1. Funnel bias plot for animal studies administering a single-dose of 
central oxytocin. 
Supplementary Figure 2. Funnel bias plot for animal studies administering a single-dose of 
systemic oxytocin. 
Supplementary Figure 3. Funnel bias plot for animal studies administering chronic central 
oxytocin. 
Supplementary Figure 4. Funnel bias plot for animal studies administering chronic systemic 
oxytocin. 
Supplementary Figure 5. Funnel bias plot for human studies measuring the effect of 
intranasal oxytocin on energy intake. 
 
